Evolving landscape of cancer survivorship research: an analysis of the Journal of Cancer Survivorship, 2007–2020

Chan, Raymond Javan; Hollingdrake, Olivia; Bui, Ut; Nekhlyudov, Larissa; Hart, Nicholas; Lui, Chi‐Wai; Feuerstein, Michael

doi:10.1007/s11764-021-01042-6

Cited by 12 publications

(20 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some cancer survivors felt that the digital platform would be more applicable to them after secondary diagnosis due to the changes experienced. Our study included perspectives from individuals who had metastatic cancer, or were caring for a family member, and are often underrepresented in research [53]. Most of the criticisms received were on how information was to be presented and who would have access to their data, which was similar to previous research [32].…”

Section: Discussionmentioning

confidence: 99%

A multinational investigation of healthcare needs, preferences, and expectations in supportive cancer care: co-creating the LifeChamps digital platform

et al. 2022

View full text Add to dashboard Cite

Purpose This study is to evaluate healthcare needs, preferences, and expectations in supportive cancer care as perceived by cancer survivors, family caregivers, and healthcare professionals. Methods Key stakeholders consisted of cancer survivors diagnosed with breast cancer, prostate cancer, or melanoma; adult family caregivers; and healthcare professionals involved in oncology. Recruitment was via several routes, and data were collected via either online surveys or telephone interviews in Greece, Spain, Sweden, and the UK. Framework analysis was applied to the dataset. Results One hundred and fifty-five stakeholders participated: 70 cancer survivors, 23 family caregivers, and 62 healthcare professionals (13 clinical roles). Cancer survivors and family caregivers’ needs included information and support on practical/daily living, as frustration was apparent with the lack of follow-up services. Healthcare professionals agreed on a multidisciplinary health service with a “focus on the patient” and availability closer to home. Most healthcare professionals acknowledged that patient-reported outcomes may provide “better individualised care”. Cancer survivors and family caregivers generally felt that the digital platform would be useful for timely personalised support and aided communication. Healthcare professionals were supportive of the “proactive” functionality of the platform and the expected advantages. Anticipated challenges were integration obstacles such as workload/infrastructure and training/support in using the new technology. Conclusions Obtaining key stakeholders’ insights provided a foundation for action to further co-create the LifeChamps digital platform to meet needs and priorities and deliver enhanced supportive care to “older” cancer survivors. Implications for cancer survivors Co-creation provided insight into gaps where digital support may enhance health and well-being.

show abstract

Section: Discussionmentioning

confidence: 99%

A multinational investigation of healthcare needs, preferences, and expectations in supportive cancer care: co-creating the LifeChamps digital platform

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Given survivors of cancer are vastly underrepresented in this research area, 39 , 80 the generalisability of the findings from ‘adults’ to ‘survivors of cancer’ will be considered. 81 Biomarker endpoints that are physiologically relevant to disease pathology and reflect earlier phase of disease progression are a useful approach to support extrapolation.…”

Section: Discussionmentioning

confidence: 99%

Home-built environment interventions and inflammation biomarkers: a systematic review and meta-analysis protocol

et al. 2022

Self Cite

View full text Add to dashboard Cite

BackgroundInflammation control is a fundamental part of chronic care in patients with a history of cancer and comorbidity. As the risk-benefit profile of anti-inflammatory drugs in cancer survivors (CS) is unclear, GPs and patients could benefit from alternative non-pharmacological treatment options for dysregulated inflammation. There is a potential for home built environment (H-BE) interventions to modulate inflammation, however, discrepancies exist between studies.AimTo evaluate the effectiveness of H-BE interventions on cancer-associated inflammation biomarkers.Design & settingA systematic review and meta-analysis of randomised and non-randomised trials in community-dwelling adults.MethodPubMed-Medline, Embase, Web of Science, and Google Scholar will be searched for clinical trials published in January 2000 onwards. We will include H-BE interventions modifying air quality, thermal comfort, non-ionising radiation, noise, nature and water. No restrictions to study population will be applied to allow deriving expectations for effects of the interventions in CS from available source populations. Outcome measures will be inflammatory biomarkers clinically and physiologically relevant to cancer. The first reviewer will independently screen articles together with GPs and extract data that will be verified by a second reviewer. The quality of studies will be assessed using the Cochrane Risk-of-Bias tools. Depending on the clinical and methodological homogeneity of populations, interventions, and outcomes, we will conduct a meta-analysis using random-effects models.ConclusionsFindings will determine the effectiveness of H-BE interventions on inflammatory parameters, guide future directions for its provision in community-dwelling CS and support GPs with safer anti-inflammatory treatment options in high-risk patients for clinical complications.

show abstract

“…Important advances in this direction include determining the 5-year chances of dying from cancer and from noncancer by age, stage, and comorbidity levels for older patients with breast, prostate, colorectal, or lung cancers in the US [5][6][7]. These measures of patients' actual prognoses provide important information for clinicians and patients to determine their treatment options, for policymakers to allocate healthcare resources, and for researchers to design trials for cancer treatments in older adults with cancer and pre-existing comorbidities [8][9][10][11][12][13].…”

Section: Introductionmentioning

confidence: 99%

Prevalence of comorbidities and their impact on survival among older adults with the five most common cancers in Taiwan: A population study

Chien

Tseng

Chen

et al. 2022

Preprint

View full text Add to dashboard Cite

Because of the cancer incidence increase and population aging in Taiwan, we aimed to assess the cancer prevalence, to summarize the comorbidities of older patients with the five most common cancers (i.e., breast, colorectal, liver, lung, and oral), and to develop a Taiwan comorbidity index (TCI) for studying their actual prognosis. The linkage of the Taiwan Cancer Registry, Cause of Death Database, and National Health Insurance Research Database was used. We followed the standard statistical learning steps to obtain a survival model with good discriminatory accuracy in predicting death due to noncancer causes, from which we obtained the TCI and defined comorbidity levels. We reported the actual prognosis by age, stage, and comorbidity level. In Taiwan, cancer prevalence nearly doubled from 2004 to 2014, and comorbidities were common among older patients. Stage was the major predictor of patients' actual prognoses. For localized and regional breast, colorectal, and oral cancers, comorbidities correlated with noncancer-related deaths. Compared with the US, the chances of dying from comorbidities in Taiwan were lower and the chances of dying from cancer were higher for breast, colorectal, and male lung cancers. These actual prognoses could help clinicians and patients in treatment decision-making and help policymakers in resource planning.

show abstract

Evolving landscape of cancer survivorship research: an analysis of the Journal of Cancer Survivorship, 2007–2020

Cited by 12 publications

References 13 publications

A multinational investigation of healthcare needs, preferences, and expectations in supportive cancer care: co-creating the LifeChamps digital platform

A multinational investigation of healthcare needs, preferences, and expectations in supportive cancer care: co-creating the LifeChamps digital platform

Home-built environment interventions and inflammation biomarkers: a systematic review and meta-analysis protocol

Prevalence of comorbidities and their impact on survival among older adults with the five most common cancers in Taiwan: A population study

Contact Info

Product

Resources

About